10.1371/journal.pone.0120829.g001
Martin Rakusa
Martin
Rakusa
Stefan J. Cano
Stefan
J. Cano
Bernadette Porter
Bernadette
Porter
Afsane Riazi
Afsane
Riazi
Alan J. Thompson
Alan
J. Thompson
Jeremy Chataway
Jeremy
Chataway
Todd A. Hardy
Todd
A. Hardy
Distribution of baseline EDSS at the time of MS relapse (a) and improvement in EDSS after treatment with intravenous methylprednisolone (b).
Public Library of Science
2015
Individual Patients
edss
Corticosteroid Response
corticosteroids
corticosteroid treatment
regression model
treatment response
baseline disability scores
patient randomised
predictive model
disability status scale
6 weeks
MS Relapses ObjectivesTo
trial data
symptom onset
sclerosis impact scale 29
MSIS
MS relapse
variable
time intervals
2015-03-18 04:31:10
Figure
https://plos.figshare.com/articles/figure/_Distribution_of_baseline_EDSS_at_the_time_of_MS_relapse_a_and_improvement_in_EDSS_after_treatment_with_intravenous_methylprednisolone_b_/1341278
<p>Distribution of baseline EDSS at the time of MS relapse (a) and improvement in EDSS after treatment with intravenous methylprednisolone (b).</p>